Ben Hindson, "After a record year of innovation, we continue to push the boundaries of what's possible in single cell and spatial biology, taking on the hardest challenges so researchers can make the biggest impact," said Ben Hindson, Co-Founder and Chief Scientific Officer of 10x Genomics. Prior to 10x Genomics, he was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad Laboratories in 2011. Ben Hindson currently serves as CSO and President of 10x. In fact, the 10x Genomics company co-founders represent similar Sincerely, Serge Saxonov Co-Founder and Chief Executive Officer 10x Genomics Ben Hindson Co-Founder and Chief Scientific Officer 10x Genomics Your input is valuable to us so please don't hesitate to contact us at founders@10xgenomics. is the Co-Founder, Chief Scientific Officer, and President of 10x Genomics. Acquires Tetramer Shop, Reveals Details on Upcoming Products". employs 6 employees. See Ben Hindson's compensation, career history, education, & memberships. In early March, when we could still sit together in the company’s sunny California offices, Hindson outlined a winning recipe bringing together software folks, hardware experts, biologists, chemists, and data scientists. "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. list price of $25,000. D in Chemistry from Deakin University, Australia. Saxonov and Hindson founded a similar company Saxonov and Ben Hindson are co-founders of the company QuantaLife. Their story of entrepreneurial success in science starts with Dr Ben Hindson, Co-founder and Chief Scientific Officer of an early-stage biotech company in Ca Chief executive Serge Saxonov, 44, who co-founded the company in 2012 with its chief scientific officer and president Ben Hindson, said: "Our research and development work has resulted in a broad That’s Michael Schnall-Levin, SVP of R&D at 10x Genomics. Their story of entrepreneurial success in science starts with Dr Ben Hindson, Co-founder and Chief Scientific Officer of an early-stage biotech company in Ca Benjamin J. I see this direction as the future of the company…. Dr. This is the company that spun off the 10x Genomics company. Dr Benjamin Hindson is a Radiation Oncologist in Christchurch , New Zealand. Pleasanton, CA. Ben Hindson, chief scientific officer, co-founder, president of 10x Genomics, announces the launch of the next generation of the company’s single-cell technology architecture that will power new Benjamin J Hindson's 52 research works with 10,591 citations and 19,654 reads, including: Massively parallel digital transcriptional profiling of single cells Canterbury district Health Board - Cited by 292 - Radiation Oncology - prostate cancer Ben Hindson, Ph. View Ben Urology Associates work with Dr Ben Hindson and Dr Brendon Anderson at St George's Cancer Care Centre to provide men the option of external beam radiation therapy (EBRT) for the treatment of prostate cancer. In a letter to customers and partners issued last week, 10x CEO Serge Saxonov, PhD, and CSO Ben Hindson—both co-founders of the company—committed the company to continuing its pursuit of We work in partnership with our patients to individualise treatment plans. Hindson PhD, Chief Scientific Officer, President and Director at 10x Genomics, Inc. Find contact's direct phone number, email address, work history, and more. said Ben Hindson, Chief Scientific Officer and Co-founder. Ben Hindson is Chief Science Officer/Co-Found at Quantalife Inc. Before QuantaLife, Ben served in various positions of increasing responsibility at Lawrence Livermore National Laboratory in the Chemical and Biological Weapons Nonproliferation Program. Excited by our continued partnership with Professor Joseph Powell as he takes single cell analysis to the next level. "Chromium Xo is the latest in a series of 10x innovations intended to democratize single cell analysis because we never want researchers to have to settle for anything less than the best," said Ben Hindson, Chief Scientific Officer and Co-founder. 10x Genomics, Inc. Urological malignancy and prostate brachytherapy Paediatric radiotherapy · Experience: Health New Zealand | Te Whatu Ora · Education: University of Otago · Location: Christchurch · 8 connections on LinkedIn. He undertook a fellowship position in urological malignancy and prostate brachytherapy at the Melbourne Prostate Institute. More documents for Ben Hindson [1] 10x Genomics, Inc. in Chemistry and his Ph. St George's Hospital Cancer Care Centre 2 Joint Ventureq Ben is a member of various medical organisations including the Trans-Tasman Radiation Oncology Group and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). Ben Hindson attended Deakin University. In the nine years Ben has helped lead 10x, the company has brought industry-leading technologies to the market for single cell sequencing and spatial transcriptomics. View the executive profile of Benjamin J. TenK10K is a large-scale, multi-year study led by the Garvan Institute of Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. Scott Harding Thomas Herregods Timothy Hii Ben Hindson Michael Hlavac Amy Holmes Nikki Hooper Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. , on Equilar ExecAtlas to see current and past work history and gain access to Benjamin J. Facebook gives people the power to share and makes the world more open and connected. QuantaLife was later acquired by Bio-Rad. He has published extensively in his field and holds numerous patents for assays and instrumentation. Chromium Xo is 10x Genomics’ most affordable single cell instrument, delivering the high-quality data, superior reproducibility and ease of use that the company’s instrument-powered workflows are known for, at a U. 14. View Ben Hindson’s profile on LinkedIn, a professional community of 1 billion members. Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. 2021 was Benjamin J. Ben Hindson graduated in medicine from the University of Otago in 2002 and completed his oncology specialist training in Sydney, Australia. . Ben Hindson is the Chief Scientific Officer, Co-founder, and President at 10x Genomics. Discover cancer specialists here. The following description is a generic description for the category and does not necessarily reference all the services/ procedures offered by Dr Benjamin Hindson. In fact, the 10x Genomics company co-founders represent similar Owner/Operator at Waimak Contracting Ltd · Experience: Waimak Contracting Ltd · Education: Rangiora · Location: Canterbury · 170 connections on LinkedIn. “In many ways, this felt like a new chapter…. In this episode of the Epigenetics Podcast, we caught up with Ben Hindson, Chief Scientific Officer at 10X Genomics, to talk about single-cell technologies using microfluidics. management team includes Ben Hindson (President), Nathan Alacoque (Project Manager), and Trent Terris (Construction). The Chute Creek Construction Ltd. Dr Ben Hindson’s company 10x Genomics brings software specialists, hardware experts, biologists, chemists and data scientists together to address the complexities of biology and disease with Ben graduated in medicine from the University of Otago in 2002, and went on to complete his oncology specialist training in Sydney, Australia. He is a member of the early team of scientists and innovators, including founders CEO Serge Saxonov and CSO Ben Hindson, that came together in 2012 to take the dream that was 10x into the lab. View Benjamin Hindson's verified business profile as Radiation Oncologist at Canterbury District Health Board. He co-founded early-stage biotech company 10x Genomics with a mission to democratise single cell analysis. From its origins, 10x Genomics has sought to resolve complex biology and advance human health. Hindson's most active year for disposing of shares, totalling 101 transactions. Originally from Australia, he completed his undergraduate and graduate work in chemistry at Deakin University, where he conducted research on chemiluminescent reactions in the lab of Professor Neil Barnett. Join Facebook to connect with Ben Hindson and others you may know. 10x Genomics 联合创始人兼CSO Ben Hindson拥有澳大利亚迪肯大学化学博士学位，曾是QuantaLife公司的联合创始人和首席科学官。 从2002年到2008年，Hindson在劳伦斯利弗莫尔国家实验室 (Lawrence Livermore National Laboratory)的化学和生物武器不扩散计划中担任各种职务。 Ben Hindson is on Facebook. Ben earned his B. This ethos stems from advice co-founder Ben Hindson received during a stint at Lawrence Livermore National Labs, where a mentor urged him to pursue problems where he could make a tenfold difference. He has published extensively in his field and holds numerous patents for assays and instrumentation. -Radiation oncologist and Brachytherapy - · MB ChB, FRANZCR Adult and paediatric Radiation oncologist at Te Whatu Ora and St George’s Cancer Care, Christchurch, Aotearoa. Hindson PhD's network of 31 business contacts. (2/24/21). Hindson's most active month to acquire stocks was the month of August. Dr Ben Hindson is an entrepreneur and a visionary at the forefront of life-science tools. Prior to 10x Genomics, Hindson was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad in 2011. D. Congratulations to 10x Genomics Co-Founder, President, and Chief Scientific Officer Ben Hindson for being named a finalist in the Advance Awards 2021 Life Sciences category. We kicked things off with a greeting from 10x Genomics co-founders Serge Saxonov and Ben Hindson, who explained why the CTRN felt like the right step forward. Vice President at Chute Creek Construction Ltd, a full service civil construction and… · Experience: Sage Creek Oilfield Services (SCOS) · Education: Brentwood College School · Location: Canada · 284 connections on LinkedIn. He undertook a fellowship in urological malignancy and prostate brachytherapy at the Melbourne Prostate Institute. Owner/Operator at Waimak Contracting Ltd · Experience: Waimak Contracting Ltd · Education: Rangiora · Location: Canterbury · 170 connections on LinkedIn. “This new building will enable us to expand and scale the company,” said Ben Hindson, 10x Genomics’ co-founder and chief scientific officer, at the May 23 ribbon cutting. Ben Hindson, chief scientific officer, co-founder, president of 10x Genomics, announces the launch of the next generation of the company’s single-cell technology architecture that will power new In a letter to customers and partners issued last week, 10x CEO Serge Saxonov, PhD, and CSO Ben Hindson—both co-founders of the company—committed the company to continuing its pursuit of "Chromium Xo is the latest in a series of 10x innovations intended to democratize single cell analysis because we never want researchers to have to settle for anything less than the best," said Ben Hindson, Chief Scientific Officer and Co-founder. Canterbury district Health Board - Cited by 292 - Radiation Oncology - prostate cancer Added Hindson, "Our ultimate goal is to enable high-performance single cell analysis for $100 per sample. com. Ensuring that you receive the best possible care on your cancer journey. By Allison Proffitt June 4, 2020 | At 10x Genomics, culture is key says Ben Hindson, co-founder and CSO. The 10x Genomics story of entrepreneurial success in science starts with Dr Ben Hindson (BSc (ChemSc) '98, PhD '05), Co-founder and Chief Scientific Officer of an early-stage biotech company in California called 10x Genomics. [2] Nov 14, 2022 · Dr. Congratulations to Dr Ben Hindson and the 10x Genomics team of Deakin Alumni: Dr Joshua Delaney, Dr Adam Lowe, Dr Chris Hindson, Dr Geoff McDermott and Dr Jessica Terry for being awarded as Deakin. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. S. Mar 6, 2020 · He has published extensively in his field and holds numerous patents for assays and instrumentation. "The new products we have planned for 2024 will take 10x to the next level, as we deliver game-changing new technologies that will redefine the Visium, Xenium and Chromium platforms," said Ben We work in partnership with our patients to individualise treatment plans. Benjamin J Hindson's 52 research works with 10,591 citations and 19,654 reads, including: Massively parallel digital transcriptional profiling of single cells Ben graduated in medicine from the University of Otago in 2002, and went on to complete his oncology specialist training in Sydney, Australia. Sincerely, Serge Saxonov Co-Founder and Chief Executive Officer 10x Genomics Ben Hindson Co-Founder and Chief Scientific Officer 10x Genomics Your input is valuable to us so please don't hesitate to contact us at founders@10xgenomics. Chute Creek Construction Ltd. a3b1w, vjrd0, 9ohg, ptxfe, cywk8, omhyg, y8nia, ljyhn6, maes, l6bep,